Navigation Links
Nventa presents HspE7 data at international HPV conference
Date:11/5/2007

Preclinical Data Indicate New HspE7 Promotes More Potent Immune Responses

SAN DIEGO, CA, Nov. 5 /PRNewswire-FirstCall/ - Nventa Biopharmaceuticals Corporation (TSX:NVN) today presented additional preclinical data on new HspE7 at the 24th International Papillomavirus conference, the largest annual gathering of scientists, clinicians and companies working in the field of human papillomavirus (HPV), taking place this week in Beijing, China. HspE7 is being developed by Nventa as a therapeutic vaccine for the treatment of diseases caused by HPV. The paper titled, "Th1 CD4 Helper T Cell Immune Responses Induced by the Combination of HspE7 and the TLR-3 Agonist Poly ICLC", was presented by Peter Emtage, Ph.D., Vice President of Research and Development at Nventa.

Results: Data from the study not only confirmed that the addition of the TLR3 agonist Poly IC potently alters the magnitude of the antigen-specific CD8 effector arm, but also that adding this moiety acts to push the immune response into a more potent Th1-biased response. This was demonstrated by a significant reduction of Interleukin-5 (IL-5) levels seen following immunization with HspE7 co-administered with Poly IC, compared to those seen with HspE7 alone. Importantly, the IL-5 decrease was accompanied by a significant increase in the level of Interferon-gamma (IFN-gamma) in the Poly IC-containing HspE7 formulations. IFN-gamma is a hallmark cytokine associated with the generation of Th1-biased immune responses. In addition to the shift from IL-5 to IFN-gamma, there was also a significant increase in the generation of antigen-specific IL-2-secreting CD4 helper T cells. In the study, IgG1, IgG2b and IgG2c antibody responses were dramatically increased as well by the incorporation of Poly IC to the immunization.

Dr. Peter Emtage commented on the data: "Taken together, the antigen-specific increase in CD8 responses, CD4 helper T cell-derived cytokines, and the antigen-specific increase in IgG2b
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
2. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
3. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
4. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
5. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
6. Retirement Living TV Presents Sex, Drugs and Rock N Roll
7. AviaraDx Presents at 2007 BIOCOM Investor Conference
8. NARSAD - the Worlds Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th
9. California Science Center Science Matters Speakers Program Presents The Science and Ethics of Fear
10. Borgata Heart & Soul Foundation Presents Third Annual Women in Wine Event
11. SafeSmart, Inc. Presents SafetyTies to Sixth Annual MedAssets Technology Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 Florida Hospital Wesley ... and Florida Hospital Carrollwood were all selected as Top ... located in Pasco County, is ranked number one for ... survey, which was conducted in partnership with an independent ... all-private bed hospital that opened in October of 2012 ...
(Date:4/17/2015)... 17, 2015 Consumers who prefer to ... modifications can now use the Insurance Pros USA website ... policy rates that are featured by leading companies quoting ... that are offered are mixed between three of the ... 79. There are now term, universal and whole policies ...
(Date:4/17/2015)... April 17, 2015 At the end ... Lounge and the “Salute to the Oscars” in the ... Hilton Hotel, overlooking the impressive Los Angeles skyline. These ... by Debbie Durkin, LA’s leading producer of sustainable product ... of the world’s premier providers of eco-friendly and socially ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative of ... Year of Soils by “Cycling for Sustainability” through California ... will travel 215 miles from Auburn, California, to the ... the impact of agriculture on water and soil in ... Wisconsin, Oregon, and Washington state, the cyclists have diverse ...
(Date:4/17/2015)... Calvary Hospital recently announced Timothy P. Barr will be ... May 11. The Fund directs all fundraising efforts in support ... J. Spinelli, who retired several months ago. , “We are ... the important work that the Fund does every year,” said ... expand and bring our signature care to people who need ...
Breaking Medicine News(10 mins):Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3
... Heart attack patients whose blood potassium levels are within a ... levels of the mineral below or above that range, says ... in heart attack patients. Researchers looked at data from ... between 2000 and 2008. Of those patients, nearly 7 percent ...
... A new classification for diagnosing fibrosis in patients with ... as accurate as currently used algorithms, but required no ... issue of Hepatology , a journal published by ... Study of Liver Diseases, details a method that synchronously ...
... 10 (HealthDay News) -- People who suffer sudden cardiac arrest ... help bystanders assess victims and begin CPR immediately, says a ... of its main goals is to increase how often bystanders ... to arms," statement lead author E. Brooke Lerner, an associate ...
... January 10, 2012. Kessler Foundation and the University ... will collaborate on clinical research projects applying virtual ... The goal, according to USC,s Albert Rizzo, PhD ... is to conduct research to develop the evidence ...
... CHICAGO (January 10, 2012) According to the results ... issue of the Journal of the American College ... knowledge about their disease and were not meaningfully involved ... approach to treatment. As a result, the study,s investigators ...
... an up-close look at multimorbidity, the coexistence of multiple chronic ... growing at an alarming rate and bankrupting the U.S. health ... percent of the American population will be living with multiple ... $1.07 trillion. In fact, more than three-fifths of health care ...
Cached Medicine News:Health News:Study Challenges Potassium Guidelines for Heart Attack Patients 2Health News:New fibrosis classification improves accuracy of diagnosis in hepatitis C 2Health News:Heart Experts Make Boosting Bystander CPR a Priority 2Health News:Kessler Foundation and USC collaborate on clinical virtual reality for disability research 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 3Health News:January/February 2012 Annals of Family Medicine 2Health News:January/February 2012 Annals of Family Medicine 3Health News:January/February 2012 Annals of Family Medicine 4Health News:January/February 2012 Annals of Family Medicine 5Health News:January/February 2012 Annals of Family Medicine 6Health News:January/February 2012 Annals of Family Medicine 7Health News:January/February 2012 Annals of Family Medicine 8Health News:January/February 2012 Annals of Family Medicine 9
(Date:4/17/2015)... 17, 2015   IBA Molecular, a global ... today that it has signed a definitive agreement to ... (IBAM NA), to Illinois Health and Science (IHS). Under IHS ... independent company headquartered in Dulles, Virginia ... of new product and footprint synergies. IBA Molecular is ...
(Date:4/17/2015)... ADELAIDE, Australia , April 17, 2015 ... the discovery and development of innovative therapeutics for the ... system, today announced the presentation of data from three ... American Association for Cancer Research (AACR) 106 th ... Philadelphia, PA USA. ...
(Date:4/16/2015)... drug commonly taken to prevent seizures in epilepsy may surprisingly ... to a study released today that will be presented at ... Washington, DC , April 18 to 25, 2015. ... at some point in their life a condition called acute ... eye to the brain gets inflamed," said study author Raj ...
Breaking Medicine Technology:Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Epilepsy Drug May Preserve Eyesight for People with MS 2
... , SANTA MONICA, Calif. and ... QUOSA, Inc., today announced that Cubist Pharmaceuticals ... between Reprints Desk,s STM Document Delivery service with QUOSA,s ... literature re-use. The integrated solution features integration with ...
... , SOUTH SAN FRANCISCO, Calif., Dec. 9 Anesiva, ... 3, 2009, Anesiva entered into an Asset Purchase Agreement which ... Technologies, Ltd., dated November 30, 2009, and sold certain assets ... British Virgin Island LLC, and Lee,s Pharmaceuticals (HK) Limited (Lee,s ...
Cached Medicine Technology:Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: